an
increase
in
operational
income
to
individuals
and
enterprises
thus
allowing
for
more
investments.
5.18
HIGH
CORPORATE
TAX
5.18.1
Undertake
Regulatory
Impact
Assessment
to
Evaluate
Impact
on
Industries
and
Review
Tax
Accordingly
The
corporate
tax
has
been
reduced
to
25%
and
this
was
addressed
in
the
2006
budget.
The
L.I.
1830
was
passed
which
saw
the
Corporate
Tax
reduced
from
28%
to
25%.
The
corporate
tax
is
now
the
same
for
both
listed
and
unlisted
companies.
The
IRS
undertook
tax
awareness
and
tax
compliance
campaigns
to
educate
the
business
community
on
the
new
corporate
tax
rate.
The
IRS
felt
that
this
tax
rate
could
result
in
an
increase
in
the
operational
income
of
corporate
organizations
thus
allowing
for
more
investments,
increased
employment
and
enhance
direct
tax
revenue.
However,
the
IRS
felt
that
the
reduction
could
result
in
a
loss
of
revenue
as
Corporate
Tax
contributes
about
50%
to
the
total
direct
tax
revenue.
This
could
be
countered
by
intensifying
tax
enforcement
and
compliance
strategies.
5.19
VAT
ON
IMPORTED
INPUTS
FOR
MANUFACTURING
5.19.1
Undertake
Regulatory
Impact
Assessment
to
Evaluate
Impact
on
Industries
and
Review
Tax
Accordingly
The
Value
Added
Tax
(VAT)
Secretariat
and
the
MoFEP
note
that
pharmaceuticals
enjoy
a
favourable
tax
policy
as
tax
on
their
manufactured
products
is
zero
rated.
However,
a
review
has
been
conducted
and
has
been
discussed
by
the
Finance
Committee
in
Parliament
with
no
objections.
5.20
TAX
STAMP
5.20.1
Undertake
Regulatory
Impact
Assessment
of
Tax
Stamp
to
Evaluate
Impact
on
Micro
and
Small
Enterprises
in
Different
Administrative
Regions
and
Review
Tax
Stamp
Accordingly
The
Tax
Stamp
has
been
reviewed
and
re-‐categorised
to
reflect
the
class
of
the
business.
The
highest
category
is
GH¢15.00
and
the
lowest
category
GH¢3.00.
Previously,
the
levels
were
117